Cristian Luput has bought MAIA on 3 days since Mar 2023

Cristian Luput is an independent director at Maia Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, including its lead program THIO (ateganosine) for non-small cell lung cancer.( He has demonstrated strong confidence in the company through multiple share purchases, including 20,000 shares on November 26, 2025, at $1.0808 each, and 18,145 shares on November 28, 2025, at an average of $1.1149, bringing his direct ownership to 437,628 shares.( Earlier, he acquired 69,282 shares in a March private placement.(

Mr. Luput is the founder and CEO of Optimus Realty Inc., a full-service real estate company in Chicago specializing in brokering, managing, and developing residential properties, with over 15 years of expertise.( His career highlights include completing multiple multi-million dollar real estate partnerships, consolidations, mergers, and acquisitions.( He serves on the boards of several charitable organizations and holds a degree in accounting and Business Administration from Babes-Bolyai University in Cluj-Napoca, Romania.(

Written by Perplexity from public sources.